Five 2026 second-rounders weighing return to college
A new eligibility ruling giving players from the 2022 high school class a fifth NCAA season has opened the door for five unsigned 2026 second-round picks to go back to college.

Eastern Conference · Atlantic · 86 updates
A new eligibility ruling giving players from the 2022 high school class a fifth NCAA season has opened the door for five unsigned 2026 second-round picks to go back to college.
LeBron James has decided to sign with the Philadelphia 76ers, a move that tilts the league's balance of power further toward the Eastern Conference. The accompanying conference power rankings measure Philadelphia's new-look roster against contenders such as the Knicks and Celtics. Contract details were not specified.
LeBron James remains undecided, with Cleveland, Miami, Philadelphia and Golden State framed as the favorites, and part of the holdup is said to be how he would fit on each roster.
Boston has signed Jordan Walsh to a contract extension. No terms disclosed.
ClutchPoints' Bailey Bassett named Neemias Queta as a possible trade piece for Boston if the team needs guard or wing help. Bassett argued Queta's role could shrink after Boston signed Mitchell Robinson and with Chris Cenac in the mix, making him expendable if his minutes drop.
Mike Conley signed a one-year deal with the Celtics this summer after leaving Minnesota. The Athletic's Jon Krawczynski said on CLNS Media's 'Celtics Daily' that Conley, despite never having played in the East, wanted to spend at least one season with a marquee organization like Boston.
Bob Myers, president of sports for the 76ers' parent company, says Philadelphia's inquiry on Jaylen Brown turned serious the moment Brad Stevens replied, "What are you offering?" Myers said on the Cousins podcast with Vince Carter and Tracy McGrady that roughly 50 conversations followed, kept quiet by both sides.
Boston has signed center Mitchell Robinson to a multi-year contract. No terms disclosed.
Boston has signed Ron Harper to a multi-year contract. No terms disclosed.